You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

ANTABUSE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Antabuse, and when can generic versions of Antabuse launch?

Antabuse is a drug marketed by Odyssey Pharms and Teva Womens and is included in three NDAs.

The generic ingredient in ANTABUSE is disulfiram. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disulfiram profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Antabuse

A generic version of ANTABUSE was approved as disulfiram by SIGMAPHARM LABS LLC on March 28th, 2011.

  Try a Trial

Drug patent expirations by year for ANTABUSE
Recent Clinical Trials for ANTABUSE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad de GuanajuatoEarly Phase 1
Laboratorios Doctor MacíasEarly Phase 1
University of California, San FranciscoPhase 2

See all ANTABUSE clinical trials

US Patents and Regulatory Information for ANTABUSE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms ANTABUSE disulfiram TABLET;ORAL 088482-001 Dec 8, 1983 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Odyssey Pharms ANTABUSE disulfiram TABLET;ORAL 088483-001 Dec 8, 1983 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.